200 TGFβ-armoring boosts potency and persistence of engineered TCR T cells, unlocking superior efficacy against HPV-positive solid tumors

• Andreia Costa,
• Gail Turner,
• Gabriela Diaz,
• Yeonjoo Oh,
• Jianguo Huang,
• Jenna Bailey,
• Cyr De Imus,
• Stephanie Busch,
• Teresa Foy,
• Pallavur Sivakumar,
• Ruth Salmon,
• Cédric Cleyrat

Affiliations

Andreia Costa

1 Department of Neurology, Centro Hospitalar e Universitário de São João, Porto, Portugal

Gail Turner

Quebec City, Quebec, Canada

Gabriela Diaz

Bristol Myers Squibb, Seattle, WA, USA

Yeonjoo Oh

Bristol Myers Squibb, Seattle, WA, USA

Jianguo Huang

Bristol Myers Squibb, Seattle, WA, USA

Jenna Bailey

Bristol Myers Squibb, Seattle, WA, USA

Cyr De Imus

Bristol Myers Squibb, Seattle, WA, USA

Stephanie Busch

Bristol Myers Squibb, Seattle, WA, USA

Teresa Foy

Bristol Myers Squibb, Seattle, WA, USA

Pallavur Sivakumar

Bristol Myers Squibb, Seattle, WA, USA

Ruth Salmon

Bristol Myers Squibb, Seattle, WA, USA

Cédric Cleyrat

Bristol Myers Squibb, Seattle, WA, USA